← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vista Scientific, Llc
Andover, MA
$3,871,572
Total funding
5
Grants
Funding over time
peak $988.9K · FY2008–10$1M$750K$500K$250K$0
'08
'09
'10
Funding mix
By agency
NIH$3,871,572 · 5
By mechanism
R44$3,315,926 · 2
R43$555,646 · 3
Investigators at Vista Scientific, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Ocular Insert for Non-Invasive Sustained Drug Delivery for the Treatment of Glauc$802,343
R44 · FY2010 · EY
Ocular Insert for Non-Invasive Sustained Drug Delivery for the Treatment of Glauc$802,258
R44 · FY2009 · EY
DEVELOPMENT OF A BIOPOLYMER-BASED TEAR FILM SUPPLEMENT$427,600
R44 · FY2000 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$409,494
R44 · FY2002 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$396,073
R44 · FY2003 · EY
DEVELOPMENT OF A BIOPOLYMER-BASED TEAR FILM SUPPLEMENT$338,600
R44 · FY2001 · EY
Nanosphere-Antibiotic Corneal Contact Lens Delivery System$186,614
R43 · FY2009 · EY
Nanosphere-Antibiotic Corneal Contact Lens Delivery System$170,532
R43 · FY2008 · EY
DEVELOPMENT OF A BIOPOLYMER-BASED TEAR FILM SUPPLEMENT$119,160
R44 · FY2002 · EY
Overnight Orthokeratology Contact Lens Manufacture$100,000
R43 · FY2004 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$98,500
R43 · FY2001 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$20,398
R44 · FY2004 · EY